Med24
Clinical Medicine 28. 10. 2026 • 2 min read • MedPage Today

Injections for Achilles Tendinopathy Flop in Randomized Trial

High-volume injections to relieve pain and disability for patients with Achilles tendinopathy failed to demonstrate significant benefit versus sham injections in a randomized trial. With 192 patients assigned to three arms ...

Injections for Achilles Tendinopathy Flop in Randomized Trial

A randomized trial involving 192 patients with gradual-onset, midportion Achilles tendinopathy revealed that high-volume injections, including saline, bupivacaine alone, bupivacaine plus hydrocortisone, or bupivacaine delivered to an ineffective site, did not demonstrate significant benefit compared to sham injections after 12 months. AUS, COVID-19, and VISA-A were key elements of this research.

Key Clinical Findings

Patients averaged approximately 50 on the Victorian Institute of Sport Assessment-Achilles (VISA-A) instrument at baseline. Improvements were similar across all three arms at week 52, with no statistically significant differences observed. At 6 weeks, the bupivacaine-steroid combination provided greater relief than the other arms, approximately 10 points on the VISA-A scale, but this advantage diminished by week 12 and numerically reversed by week 26.

Sponsored content

Healthcare Cost Analysis

Healthcare costs were more favorable with the bupivacaine-steroid combination compared to the sham injection, with greater than 90% certainty of cost-effectiveness at thresholds of AUS$50,000 to $100,000. Patients received approximately 10 mL of 0.5% bupivacaine and 40 mL saline, or 25-mg hydrocortisone in the steroid-included arm. Sham injections were delivered at least 10 mm anterior to the junction, producing a numbing effect. Adverse effects were generally mild and infrequent, with aggravated Achilles pain occurring in varying percentages across the arms. Eleven participants did not collect VISA-A scores at week 52, and per-protocol analyses yielded similar results. The study acknowledged limitations including recruitment through social media and adaptations due to the **COVID-19** pandemic.

Original Scientific Source
MedPage Today
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement